[1]
|
Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A. (2023) Cancer Statistics, 2023. Ca: A Cancer Journal for Clinicians, 73, 17-48. https://doi.org/10.3322/caac.21763
|
[2]
|
Wang, H. and Mao, X.Y. (2020) Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer. Drug Design Development and Therapy, 14, 2423-2433. https://doi.org/10.2147/DDDT.S253961
|
[3]
|
Kong, X.N., Moran, M.S., Zhang, N., Haffty, B. and Yang, Q.F. (2011) Meta-Analysis Confirms Achieving Pathological Complete Response after Neoadjuvant Chemotherapy Predicts Favourable Prognosis for Breast Cancer Patients. European Journal of Cancer, 47, 2084-2090. https://doi.org/10.1016/j.ejca.2011.06.014
|
[4]
|
Denkert, C., Von Minckwitz, G., Darb-Esfahani, S., Lederer, B., Heppner, B.I., Weber, K.E., et al. (2018) Tumour-Infiltrating Lymphocytes and Prognosis in Different Subtypes of Breast Cancer: A Pooled Analysis of 3771 Patients Treated with Neoadjuvant Therapy. The Lancet Oncology, 19, 40-50. https://doi.org/10.1016/S1470-2045(17)30904-X
|
[5]
|
Savas, P., Virassamy, B., Ye, C.Z., Salim, A., Mintoff, C.P., Caramia, F., et al. (2018) Single-Cell Profiling of Breast Cancer T Cells Reveals a Tissue-Resident Memory Subset Associated with Improved Prognosis. Nature Medicine, 24, 986-993. https://doi.org/10.1038/s41591-018-0078-7
|
[6]
|
Hadrup, S., Donia, M. and Thor Straten, P. (2013) Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment. Cancer Microenvironment: Official Journal of the International Cancer Microenvironment Society, 6, 123-133. https://doi.org/10.1007/s12307-012-0127-6
|
[7]
|
Nishimura, T., Nakui, M., Sato, M., Iwakabe, K., Kitamura, H., Sekimoto, M., Ohta, A., Koda, T. and Nishimura, S. (2000) The Critical Role of Th1-Dominant Immunity in Tumor Immunology. Cancer Chemotherapy and Pharmacology, 46, S52-S61. https://doi.org/10.1007/PL00014051
|
[8]
|
Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F. and Delort, L. (2023) Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment. International Journal of Molecular Sciences, 24, Article No. 4002. https://doi.org/10.3390/ijms24044002
|
[9]
|
Salgado, R., Denkert, C., Demaria, S., Sirtaine, N., Klauschen, F., Pruneri, G., et al. (2015) The Evaluation of Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Recommendations by an International TILs Working Group 2014. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 26, 259-271. https://doi.org/10.1093/annonc/mdu450
|
[10]
|
Stanton, S.E. and Disis, M.L. (2016) Clinical Significance of Tumor-Infiltrating Lymphocytes in Breast Cancer. Journal for Immunotherapy of Cancer, 4, 59. https://doi.org/10.1186/s40425-016-0165-6
|
[11]
|
Salemme, V., Centonze, G., Cavallo, F., Defilippi, P. and Conti, L. (2021) The Crosstalk between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy. Frontiers in Oncology, 11, Article ID: 610303. https://doi.org/10.3389/fonc.2021.610303
|
[12]
|
Orcutt-Jahns, B., Junior, J.R.L., Rockne, R.C., Matache, A., Branciamore, S., Hung, E., et al. (2023) Systems Profiling Reveals Recurrently Dysregulated Cytokine Signaling Responses in ER Breast Cancer Patients’ Blood. https://doi.org/10.1101/2023.10.31.564987
|
[13]
|
Aguilar-Cazares, D., Chavez-Dominguez, R., Marroquin-Muciño, M., Perez-Medina, M., Benito-Lopez, J.J., et al. (2022) The Systemic-Level Repercussions of Cancer-Associated Inflammation Mediators Produced in the Tumor Microenvironment. Frontiers in Endocrinology, 13, Article ID: 929572. https://doi.org/10.3389/fendo.2022.929572
|
[14]
|
Savas, P., Salgado, R., Denkert, C., Sotiriou, C., Darcy, P.K., Smyth, M.J. and Loi, S. (2016) Clinical Relevance of Host Immunity in Breast Cancer: From TILs to the Clinic. Nature Reviews. Clinical Oncology, 13, 228-241. https://doi.org/10.1038/nrclinonc.2015.215
|
[15]
|
Cianci, R., Pagliari, D., Pietroni, V., Landolfi, R. and Pandolfi, F. (2010) Tissue Infiltrating Lymphocytes: The Role of Cytokines in Their Growth and Differentiation. Journal of Biological Regulators and Homeostatic Agents, 24, 239-249.
|
[16]
|
Radosevic-Robin, N., Béguinot, M. and Penault-Llorca, F. (2017) Evaluation of the Immune Infiltrate in Breast Cancer. Bulletin Du Cancer, 104, 52-68. https://doi.org/10.1016/j.bulcan.2016.11.010
|
[17]
|
La Casse, C.J., Janikashvili, N., Larmonier, C.B., Alizadeh, D., Hanke, N., Kartchner, J., et al. (2011) Th-1 Lymphocytes Induce Dendritic Cell Tumor Killing Activity by an IFN-γ-Dependent Mechanism. Journal of Immunology (Baltimore, Md.: 1950), 187, 6310-6317. https://doi.org/10.4049/jimmunol.1101812
|
[18]
|
Nicolini, A., Carpi, A. and Rossi, G. (2006) Cytokines in Breast Cancer. Cytokine & Growth Factor Reviews, 17, 325-337. https://doi.org/10.1016/j.cytogfr.2006.07.002
|
[19]
|
Zhu, X., Du, L.B., Feng, J.G., Ling, Y.T. and Xu, S.H. (2014) Clinicopathological and Prognostic Significance of Serum Cytokine Levels in Breast Cancer. Clinical Laboratory, 60, 1145-1151. https://doi.org/10.7754/Clin.Lab.2013.130738
|
[20]
|
Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444. https://doi.org/10.1038/nature07205
|
[21]
|
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., et al. (2007) Toll-Like Receptor 4-Dependent Contribution of the Immune System to Anticancer Chemotherapy and Radiotherapy. Nature Medicine, 13, 1050-1059. https://doi.org/10.1038/nm1622
|
[22]
|
Yang, S.X., Wei, W.S., Ouyan, Q.W., Jiang, Q.H., Zou, Y.F., Qu, W., et al. (2016) Interleukin-12 Activated CD8+ T Cells Induces Apoptosis in Breast Cancer Cells and Reduces Tumor Growth. Biomedicine & Pharmacotherapy, 84, 1466-1471. https://doi.org/10.1016/j.biopha.2016.10.046
|
[23]
|
Kawaguchi, K., Sakurai, M., Yamamoto, Y., Suzuki, E., Tsuda, M., Kataoka, T.R., et al. (2019) Alteration of Specific Cytokine Expression Patterns in Patients with Breast Cancer. Scientific Reports, 9, Article No. 2924. https://doi.org/10.1038/s41598-019-39476-9
|
[24]
|
Huang, X.J., Ren, Q.H., Yang, L.X., Cui, D., Ma, C.Y., Zheng, Y.L. and Wu, J.J. (2023) Immunogenic Chemotherapy: Great Potential for Improving Response Rates. Frontiers in Oncology, 13, Article ID: 1308681. https://doi.org/10.3389/fonc.2023.1308681
|
[25]
|
Marciscano, A.E. and Anandasabapathy, N. (2021) The Role of Dendritic Cells in Cancer and Anti-Tumor Immunity. Seminars in Immunology, 52, Article ID: 101481. https://doi.org/10.1016/j.smim.2021.101481
|
[26]
|
Ogiya, R., Niikura, N., Kumaki, N., Bianchini, G., Kitano, S., Iwamoto, T., Hayashi, N., et al. (2016) Comparison of Tumor-Infiltrating Lymphocytes between Primary and Metastatic Tumors in Breast Cancer Patients. Cancer Science, 107, 1730-1735. https://doi.org/10.1111/cas.13101
|
[27]
|
Ruffell, B., DeNardo, D.G., Affara, N.I. and Coussens, L.M. (2010) Lymphocytes in Cancer Development: Polarization towards Pro-Tumor Immunity. Cytokine & Growth Factor Reviews, 21, 3-10. https://doi.org/10.1016/j.cytogfr.2009.11.002
|